Other
Noncontrolling interests in subsidiaries
Cigna Noncontrolling interests in subsidiaries increased by 44.1% to $232M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $188M to $232M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interests in subsidiaries shows an upward trend with a 87.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
Categoryequity
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Changes reflect the acquisition or divestiture of partial interests in subsidiaries or the varying profitability of those specific entities.
Detailed definition
Noncontrolling interest represents the portion of equity in a subsidiary that is not attributable, directly or indirectl...
Peer comparison
Common in large conglomerates or companies with complex joint venture structures.
Metric ID:
other_minority_interestHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7M | $12M | $18M | $22M | $30M | $42M | $13M | $16M | $19M | $11M | $21M | $169M | $195M | $203M | $210M | $188M | $216M | $209M | $161M | $232M |
| QoQ Change | — | +71.4% | +50.0% | +22.2% | +36.4% | +40.0% | -69.0% | +23.1% | +18.8% | -42.1% | +90.9% | +704.8% | +15.4% | +4.1% | +3.4% | -10.5% | +14.9% | -3.2% | -23.0% | +44.1% |
| YoY Change | — | — | — | — | +328.6% | +250.0% | -27.8% | -27.3% | -36.7% | -73.8% | +61.5% | +956.3% | +926.3% | >999% | +900.0% | +11.2% | +10.8% | +3.0% | -23.3% | +23.4% |
Range$7M – $232M
CAGR+109.0%
Avg YoY Growth+314.2%
Median YoY Growth+17.3%
Noncontrolling interests in subsidiaries at Other Companies
Frequently Asked Questions
- What is Cigna's noncontrolling interests in subsidiaries?
- Cigna (CI) reported noncontrolling interests in subsidiaries of $232M in Q1 2026.
- How has Cigna's noncontrolling interests in subsidiaries changed year-over-year?
- Cigna's noncontrolling interests in subsidiaries increased by 23.4% year-over-year, from $188M to $232M.
- What is the long-term trend for Cigna's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Cigna's noncontrolling interests in subsidiaries has grown at a 87.2% compound annual growth rate (CAGR), from $7M to $161M.
- What does noncontrolling interests in subsidiaries mean?
- The portion of a subsidiary's equity owned by outside investors rather than the parent company.